Nunez-Cruz, Selene <br/><br/>
Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)  Nov 2012 
 - 994-1004 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5586 
<br/><br/><label>Standard No.: </label>10.1593/neo.121262  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Transformation, Neoplastic--genetics<br/>Complement Activation--immunology<br/>Complement C3--deficiency<br/>Complement C5a--antagonists & inhibitors<br/>Complement System Proteins--drug effects<br/>Endothelial Cells--drug effects<br/>Female<br/>Humans<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Neovascularization, Pathologic--immunology<br/>Ovarian Neoplasms--blood supply<br/>Peptides, Cyclic--pharmacology<br/>Protein Isoforms<br/>Vascular Endothelial Growth Factor A--metabolism